Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update Q and A

被引：1
|
作者：
Raab, Rachel [1 ]
Ismaila, Nofisat [2 ]
Andre, Fabrice [3 ]
Stearns, Vered [4 ]
Kalinsky, Kevin [5 ]
机构：
[1] Messino Canc Ctr, Asheville, NC USA
[2] Amer Soc Clin Oncol, 2318 Mill Rd,Ste 800, Alexandria, VA 22314 USA
[3] Inst Gustave Roussy, Paris, France
[4] Johns Hopkins Univ, Baltimore, MD USA
[5] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA
来源：
JCO ONCOLOGY PRACTICE | 2022年 / 18卷 / 09期
关键词：
DISTANT RECURRENCE; PREDICTION; INDEX; DECISIONS; THERAPY;
D O I：
10.1200/OP.22.00230
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：646 / +
页数：4
相关论文
共 50 条
  • [1] Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update
    Andre, Fabrice
    Ismaila, Nofisat
    Allison, Kimberly H.
    Barlow, William E.
    Collyar, Deborah E.
    Damodaran, Senthil
    Henry, N. Lynn
    Jhaveri, Komal
    Kalinsky, Kevin
    Kuderer, Nicole M.
    Litvak, Anya
    Mayer, Erica L.
    Pusztai, Lajos
    Raab, Rachel
    Wolff, Antonio C.
    Stearns, Vered
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : 1816 - +
  • [2] Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update (vol 40, pg 1816, 2022)
    Andre
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (22) : 2514 - 2514
  • [3] Recent ASCO Guideline on the Use of Biomarkers for Adjuvant Systemic Therapy in Early-Stage Invasive Breast Cancer
    Copur, Mehmet S.
    Ramaekers, Ryan
    Gauchan, Dron
    Norvell, Max
    Clark, Douglas
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (32) : 3943 - +
  • [4] Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update
    Denduluri, Neelima
    Somerfield, Mark R.
    Chavez-MacGregor, Mariana
    Comander, Amy H.
    Dayao, Zoneddy
    Eisen, Andrea
    Freedman, Rachel A.
    Gopalakrishnan, Ragisha
    Graff, Stephanie L.
    Hassett, Michael J.
    King, Tari A.
    Lyman, Gary H.
    Maupin, Gillian Rice
    Nunes, Raquel
    Perkins, Cheryl L.
    Telli, Melinda L.
    Trudeau, Maureen E.
    Wolff, Antonio C.
    Giordano, Sharon H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06) : 685 - +
  • [5] Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update Summary
    Andre, Fabrice
    Ismaila, Nofisat
    Stearns, Vered
    [J]. JOURNAL OF ONCOLOGY PRACTICE, 2019, 15 (09) : 495 - +
  • [6] Adjuvant chemotherapy for early-stage breast cancer
    McArthur, Heather L.
    Hudis, Clifford A.
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2007, 21 (02) : 207 - +
  • [7] Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline Update Q and A
    Clark, Amy S.
    Cobain, Erin F.
    Dayao, Zoneddy
    Somerfield, Mark R.
    DeMichele, Angela
    Henry, N. Lynn
    [J]. JCO ONCOLOGY PRACTICE, 2022, 18 (12) : 830 - +
  • [8] Adjuvant Abemaciclib Plus Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Guideline Rapid Recommendation Update Q and A
    Freedman, Rachel A.
    Graff, Stephanie L.
    Somerfield, Mark R.
    Telli, Melinda L.
    Wolff, Antonio C.
    Giordano, Sharon H.
    [J]. JCO ONCOLOGY PRACTICE, 2022, 18 (07) : 516 - +
  • [9] Optimizing adjuvant chemotherapy in early-stage breast cancer
    Perez, Edith
    Muss, Hyman B.
    [J]. ONCOLOGY-NEW YORK, 2005, 19 (14): : 1759 - 1767
  • [10] Role of adjuvant endocrine therapy in early-stage breast cancer
    Muss, HB
    [J]. SEMINARS IN ONCOLOGY, 2001, 28 (04) : 313 - 321
12345